Tri Locum Partners’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-196,390	Closed	-$20.9M	–	79
2022 Q3	$20.9M	Buy	+196,390	New	+$20.9M	5.73%	4
2021 Q1	–	Sell	-7,178	Closed	-$688K	–	62
2020 Q4	$688K	Buy	+7,178	New	+$688K	0.25%	38